Drugs Made In America Acquisition Corp. SEC EDGAR Filings (CIK 0002028614)

SEC EDGAR filings, ownership reports, and insider transactions for Drugs Made In America Acquisition Corp..

Symbol
DMAA, DMAAR, DMAAU on Nasdaq
Industry
Blank Checks (Office Of Real Estate & Construction)
Business address
2 Pelican Dr., Fort Lauderdale, FL, 33301
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Drugs Made In America Acquisition Corp. has filed 55 SEC EDGAR filings since 01 Aug 2024

Latest Filings

Recent SEC filings for Drugs Made In America Acquisition Corp. including 8-K, 10-Q, NT 10-Q and more.

Form type Document Filing Description Filing date Reporting date File number(s)
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 06 Mar 2026 06 Mar 2026 001-42467
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 06 Mar 2026 28 Feb 2026 001-42467
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 18 Nov 2025 30 Sep 2025 001-42467
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 18 Nov 2025 08 Oct 2025 001-42467
NT 10-Q Open NT 10-Q document View SEC filing for NT 10-Q NOTIFICATION OF LATE FILING 17 Nov 2025 30 Sep 2025 001-42467
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 12 Nov 2025 005-94909
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 Aug 2025 30 Jun 2025 001-42467
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Aug 2025 005-94909
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 20 May 2025 31 Mar 2025 001-42467
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 15 May 2025 005-94909
NT 10-Q Open NT 10-Q document View SEC filing for NT 10-Q NOTIFICATION OF LATE FILING 15 May 2025 31 Mar 2025 001-42467
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 15 May 2025 005-94909
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 15 May 2025 005-94909
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 May 2025 005-94909
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 May 2025 005-94909
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K ANNUAL REPORT 31 Mar 2025 31 Dec 2024 001-42467
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 03 Mar 2025 005-94909
8-K Open 8-K document View SEC filing for 8-K CURRENT REPORT 25 Feb 2025 18 Feb 2025 001-42467
8-K Open 8-K document View SEC filing for 8-K CURRENT REPORT 24 Feb 2025 20 Feb 2025 001-42467
4 Open 4 document View SEC filing for 4 18 Feb 2025 18 Feb 2025
4 Open 4 document View SEC filing for 4 18 Feb 2025 18 Feb 2025
4 Open 4 document View SEC filing for 4 04 Feb 2025 29 Jan 2025
4 Open 4 document View SEC filing for 4 04 Feb 2025 29 Jan 2025
8-K Open 8-K document View SEC filing for 8-K CURRENT REPORT 04 Feb 2025 29 Jan 2025 001-42467
4 Open 4 document View SEC filing for 4 03 Feb 2025 29 Jan 2025
4 Open 4 document View SEC filing for 4 03 Feb 2025 29 Jan 2025
4 Open 4 document View SEC filing for 4 03 Feb 2025 29 Jan 2025
4 Open 4 document View SEC filing for 4 03 Feb 2025 29 Jan 2025
8-K Open 8-K document View SEC filing for 8-K CURRENT REPORT 30 Jan 2025 27 Jan 2025 001-42467
424B4 Open 424B4 document View SEC filing for 424B4 PROSPECTUS 29 Jan 2025 333-281170
EFFECT Open EFFECT document View SEC filing for EFFECT 27 Jan 2025 333-281170
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Jan 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Jan 2025
POS AM Open POS AM document View SEC filing for POS AM REGISTRATION STATEMENT 22 Jan 2025 333-281170
POS AM Open POS AM document View SEC filing for POS AM POST-EFFECTIVE AMENDMENT 14 Jan 2025 333-281170
3 Open 3 document View SEC filing for 3 10 Jan 2025 07 Jan 2025
3 Open 3 document View SEC filing for 3 10 Jan 2025 07 Jan 2025
3 Open 3 document View SEC filing for 3 10 Jan 2025 07 Jan 2025
3 Open 3 document View SEC filing for 3 10 Jan 2025 07 Jan 2025
3 Open 3 document View SEC filing for 3 10 Jan 2025 07 Jan 2025
3 Open 3 document View SEC filing for 3 10 Jan 2025 07 Jan 2025
CERT Open CERT document View SEC filing for CERT 08 Jan 2025 001-42467
EFFECT Open EFFECT document View SEC filing for EFFECT 07 Jan 2025 333-281170
8-A12B Open 8-A12B document View SEC filing for 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 07 Jan 2025 001-42467
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 06 Jan 2025 333-281170
CORRESP Open CORRESP document View SEC filing for CORRESP 03 Jan 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 03 Jan 2025
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 09 Dec 2024 333-281170
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 25 Nov 2024 333-281170
S-1/A Open S-1/A document View SEC filing for S-1/A AMENDMENT NO. 3 TO FORM S-1 07 Nov 2024 333-281170
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 27 Sep 2024 333-281170
CORRESP Open CORRESP document View SEC filing for CORRESP 06 Sep 2024
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 06 Sep 2024 333-281170
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 27 Aug 2024 333-281170
S-1 Open S-1 document View SEC filing for S-1 REGISTRATION STATEMENT 01 Aug 2024 333-281170

About this filer

Drugs Made In America Acquisition Corp. files with the SEC under CIK 0002028614. This page aggregates EDGAR filings and related ownership activity.

Industry: Blank Checks.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages